While adult and AYA B-ALL cases frequently exhibit promoter hypermethylation of tumor suppressor genes such as CDKN1C, CDKN2A, and TP73, pediatric cases often show transcriptional silencing through alternative, methylation-independent mechanisms. This evidence concerns the gene CDKN2A and acute lymphoblastic leukemia.